Mark D. Aupperlee

944 citations
26 papers · 791 · h-index 18

Impact in

  • Oncology top 10%
    • Cancer Cells and Metastasis
    • Cancer Risks and Factors
    • Cytokine Signaling Pathways and Interactions
    • HER2/EGFR in Cancer Research
  • Genetics top 10%
    • Estrogen and related hormone effects

Papers in

    • Cancer Risks and Factors 7
    • Cancer Cells and Metastasis 6
    • Cytokine Signaling Pathways and Interactions 3
    • Estrogen and related hormone effects 10

Mark D. Aupperlee

26 papers receiving 783 citations

Peers

Mark D. Aupperlee
Comparison fields: 5 of 84
  • Oncology 360
  • Genetics 309
  • Cancer Research 139
  • Health, Toxicology and Mutagenesis 62
  • Reproductive Medicine 35
Replace Shuji Nagasaki with:
Shuji Nagasaki Japan
Tara C. Polek United States
BK Vonderhaar United States
Sonia Godoy‐Tundidor Austria
Shigeaki Kato Japan
Jan Novotný Czechia
Aurélie Fabre France
Suwei Dong China
C A Donaldson United States
Marc Arnush United States
Mark D. Aupperlee relative to Shuji Nagasaki Japan Shuji Nagasaki's profile →
Citations per field
00.5×2×2.5×
Shuji Nagasaki · 1×
Citations per year

Countries citing papers authored by Mark D. Aupperlee

Since Specialization
Citations

This map shows the geographic impact of Mark D. Aupperlee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Aupperlee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Aupperlee more than expected).

Fields of papers citing papers by Mark D. Aupperlee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Aupperlee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Aupperlee. The network helps show where Mark D. Aupperlee may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark D. Aupperlee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark D. Aupperlee Line = papers co-authored together Mark D. Aupperlee links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2005101
2 201064
3 200764
4 200858
5 201357
6 200853
7 200745
8 200643
9 201340
10 200930
11 200829
12 201429
13 200227
14 201625
15 201524
16 202022
17 201721
18 201019
19 200212
20 20129

About Mark D. Aupperlee

Mark D. Aupperlee is a scholar working on Oncology, Genetics, Molecular Biology, Public Health, Environmental and Occupational Health and Cancer Research, having authored 26 papers that have together received 791 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (10 papers), Cancer Risks and Factors (7 papers), Cancer Cells and Metastasis (6 papers), Ocular Surface and Contact Lens (5 papers), Cytokine Signaling Pathways and Interactions (3 papers), Photodynamic Therapy Research Studies (2 papers), Inflammatory mediators and NSAID effects (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Oncology (360 citations), Genetics (309 citations), Cancer Research (139 citations), Health, Toxicology and Mutagenesis (62 citations) and Reproductive Medicine (35 citations). Mark D. Aupperlee has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include Sandra Z. Haslam, Anastasia Kariagina, Richard C. Schwartz, Yong Zhao, Jeffrey R. Leipprandt, Jessica M. Bennett, Ying Tan, L. Karl Olson, John L. Ubels and Janet R. Osuch. Their work appears in journals such as Endocrinology, Breast Cancer Research, Advances in experimental medicine and biology, Oncotarget and Translational Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact